These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11941264)

  • 21. Ertapenem: a review of its use in the management of bacterial infections.
    Curran M; Simpson D; Perry C
    Drugs; 2003; 63(17):1855-78. PubMed ID: 12921489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ertapenem. A new carbapenem in a single dose for community acquired infection].
    Di Perri G; Bargiacchi O; Garazzino S; Audagnotto S; De Rosa FG
    Ann Ital Med Int; 2005; 20(3):3 p following 204. PubMed ID: 16250188
    [No Abstract]   [Full Text] [Related]  

  • 23. Revisiting combination antibiotic therapy for community-acquired invasive Streptococcus pneumoniae pneumonia.
    Mufson MA; Stanek RJ
    Clin Infect Dis; 2006 Jan; 42(2):304-6. PubMed ID: 16355349
    [No Abstract]   [Full Text] [Related]  

  • 24. Carbapenems: a potent class of antibiotics.
    Nicolau DP
    Expert Opin Pharmacother; 2008 Jan; 9(1):23-37. PubMed ID: 18076336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
    Burgess DS; Frei CR
    J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of complicated community-acquired infections with ertapenem, the first Group 1 carbapenem. Introduction.
    Goldstein EJ
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii5-6. PubMed ID: 15228047
    [No Abstract]   [Full Text] [Related]  

  • 27. Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria.
    Pintado V; San Miguel LG; Grill F; Mejía B; Cobo J; Fortún J; Martín-Dávila P; Moreno S
    J Infect; 2008 Mar; 56(3):185-90. PubMed ID: 18280570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parenteral polymyxin B use in patients with multidrug-resistant gram-negative bacteremia and urinary tract infections: a retrospective case series.
    Pastewski AA; Caruso P; Parris AR; Dizon R; Kopec R; Sharma S; Mayer S; Ghitan M; Chapnick EK
    Ann Pharmacother; 2008 Sep; 42(9):1177-87. PubMed ID: 18664609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of ertapenem for consolidation therapy of extended-spectrum beta-lactamase-producing gram-negative infections: a case series report.
    Berg ML; Crank CW; Philbrick AH; Hayden MK
    Ann Pharmacother; 2008 Feb; 42(2):207-12. PubMed ID: 18230703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in Antananarivo, Madagascar.
    Randrianirina F; Soares JL; Carod JF; Ratsima E; Thonnier V; Combe P; Grosjean P; Talarmin A
    J Antimicrob Chemother; 2007 Feb; 59(2):309-12. PubMed ID: 17138569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ertapenem versus ceftriaxone for the treatment of complicated infections: a meta-analysis of randomized controlled trials.
    Bai N; Sun C; Wang J; Cai Y; Liang B; Zhang L; Liu Y; Wang R
    Chin Med J (Engl); 2014; 127(6):1118-25. PubMed ID: 24622445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ambulatory treatment with intramuscular ceftriaxone.
    Schlaeffer F
    J Chemother; 1989 Jul; 1(4 Suppl):655-6. PubMed ID: 16312577
    [No Abstract]   [Full Text] [Related]  

  • 33. Properties and potential of ertapenem.
    Livermore DM; Sefton AM; Scott GM
    J Antimicrob Chemother; 2003 Sep; 52(3):331-44. PubMed ID: 12917243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of resistance to beta-lactams in some common Gram-negative bacteria causing nosocomial infections.
    Suárez CJ; Lolans K; Villegas MV; Quinn JP
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):915-22. PubMed ID: 16307504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pneumonia, tuberculosis, and urinary tract infections in pregnancy.
    Riley LE
    Curr Clin Top Infect Dis; 1999; 19():181-97. PubMed ID: 10472486
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro activities of ertapenem against drug-resistant Streptococcus pneumoniae and other respiratory pathogens from 12 Asian countries.
    Song JH; Ko KS; Lee MY; Park S; Baek JY; Lee JY; Heo ST; Kwon KT; Ryu SY; Oh WS; Peck KR; Lee NY
    Diagn Microbiol Infect Dis; 2006 Dec; 56(4):445-50. PubMed ID: 16949783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of intramuscularly administered ertapenem.
    Musson DG; Majumdar A; Birk K; Holland S; Wickersham P; Li SX; Mistry G; Fisher A; Waldman S; Greenberg H; Deutsch P; Rogers JD
    Antimicrob Agents Chemother; 2003 May; 47(5):1732-5. PubMed ID: 12709348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Infection due to gram negative rod].
    Kobayashi Y
    Nihon Rinsho; 1993 Jan; 51 Suppl():893-9. PubMed ID: 8459626
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy of ertapenem in the treatment of early ventilator-associated pneumonia caused by extended-spectrum beta-lactamase-producing organisms in an intensive care unit.
    Bassetti M; Righi E; Fasce R; Molinari MP; Rosso R; Di Biagio A; Mussap M; Pallavicini FB; Viscoli C
    J Antimicrob Chemother; 2007 Aug; 60(2):433-5. PubMed ID: 17540673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of ertapenem in outpatients with complicated urinary tract infections.
    Zhou J; Sulaiman Z; Llorin RM; Hee KH; Lee LS; Lye DC; Fisher DA; Tam VH
    J Antimicrob Chemother; 2014 Sep; 69(9):2517-21. PubMed ID: 24797063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.